Literature DB >> 24185586

Unreported use of an herbal supplement resulting in decreased clearance of intravenous busulfan in a patient undergoing auto-SCT.

J Carter1, R F Yeh2, I Braunschweig1, S K Barta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24185586     DOI： 10.1038/bmt.2013.169

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  An in vivo analysis of the herbal compound essiac.

Authors:  Blair J N Leonard; Deborah A Kennedy; Fong-Chi Cheng; Keng-Kuang Chang; Dugald Seely; Edward Mills
Journal:  Anticancer Res       Date:  2006 Jul-Aug       Impact factor: 2.480

Review 2.  The prevalence of complementary/alternative medicine in cancer: a systematic review.

Authors:  E Ernst; B R Cassileth
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

3.  Hepatoprotective effects of Arctium lappa on carbon tetrachloride- and acetaminophen-induced liver damage.

Authors:  S C Lin; T C Chung; C C Lin; T H Ueng; Y H Lin; S Y Lin; L Y Wang
Journal:  Am J Chin Med       Date:  2000       Impact factor: 4.667

4.  Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo).

Authors:  I Buggia; M Zecca; E P Alessandrino; F Locatelli; G Rosti; A Bosi; A Pession; B Rotoli; I Majolino; A Dallorso; M B Regazzi
Journal:  Anticancer Res       Date:  1996 Jul-Aug       Impact factor: 2.480

5.  Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.

Authors:  Borje S Andersson; Peter F Thall; Timothy Madden; Daniel Couriel; Xuemei Wang; Hai T Tran; Paolo Anderlini; Marcos de Lima; James Gajewski; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

6.  Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats.

Authors:  Z Guo; T J Smith; E Wang; N Sadrieh; Q Ma; P E Thomas; C S Yang
Journal:  Carcinogenesis       Date:  1992-12       Impact factor: 4.944

7.  Pharmacokinetic and metabolic studies of high-dose busulphan in adults.

Authors:  M Hassan; G Oberg; H Ehrsson; M Ehrnebo; I Wallin; B Smedmyr; T Tötterman; S Eksborg; B Simonsson
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  In vitro analysis of the herbal compound Essiac.

Authors:  Dugald Seely; Deborah A Kennedy; Stephen P Myers; Phillip A Cheras; David Lin; Rachel Li; Trudy Cattley; Petta-Anne Paul Brent; Edward Mills; Blair J N Leonard
Journal:  Anticancer Res       Date:  2007 Nov-Dec       Impact factor: 2.480
  8 in total
  3 in total

Review 1.  Critical evaluation of causality assessment of herb-drug interactions in patients.

Authors:  Charles Awortwe; Memela Makiwane; Helmuth Reuter; Christo Muller; Johan Louw; Bernd Rosenkranz
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

Review 2.  HDI Highlighter, The First Intelligent Tool to Screen the Literature on Herb-Drug Interactions.

Authors:  Anthony Cnudde; Patrick Watrin; Florence Souard
Journal:  Clin Pharmacokinet       Date:  2022-05-31       Impact factor: 5.577

Review 3.  Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Authors:  Alan L Myers; Jitesh D Kawedia; Richard E Champlin; Mark A Kramer; Yago Nieto; Romi Ghose; Borje S Andersson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-08-17       Impact factor: 4.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.